Membrane Emulsification was used to encapsulate yeast cells and form microparticles. W/O emulsions were produced using a Dispersion Cell; the aqueous phase consisted of gelatin/chitosan, or pure gelatin solution, containing yeast cells, the continuous phase was 2 wt.% of SPAN 80 in kerosene. Varying the dispersed phase flux (from 70 to 350 L h -1 m -2 ) and the shear stress (from 17 to 1 Pa) applied on the membrane surface droplet sizes of between 60 to 340 µm were produced, with a coefficient of variation of 17% under the best operating conditions. The liquid drops were loaded with increasing amount of yeast (3.14 x 10 7 to 3.14 x 10 8 cells/ mL). The stability and uniformity of the emulsions was independent of the cell concentration. PTFE coated hydrophobic membrane produced smaller W/O drops compared to FAS coated membranes. The liquid polymeric droplets were solidified in solid particles using thermal gelation and/or ionic crosslinking, obtaining yeast encapsulated particles sized ~100 µm.
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Introduction
The encapsulation of living microorganisms as well as cells, for the purpose of a therapy, is a relatively recent and promising technique relevant to a broad range of sectors, from medicine to the food industry. The technology of cell encapsulation is applied as a method to deliver therapeutics in a desired rate and for longer period, by controlled or triggered release of an active ingredient. Unlike the encapsulation of proteins, encapsulated cells can be used to synthetize the therapeutic product, giving a physiological concentration of an active ingredient with time[1].
Furthermore, due to the in-situ manufacture of the active ingredient the risk of a toxic release of a therapeutic is avoided in the case of unexpected breaking of the encapsulated particles [1] . The immobilization of cells in particles is widely discussed in tissue engineering; the possibility to encapsulate non-human cells reduces the host's immune system response, facilitating transplantation as an alternative to the limited donor tissues available [1] . The technique of cell encapsulation is being used for the production of "Bio artificial Pancreas" [2] , immunobarrier for islet cells transplantation [2] [3] [4] , and the encapsulation of stem cells [5, 6] . Encapsulation of living cells was also suggested for the production of chemicals such as alcohol, organic acids, steroids, antibiotics, vaccines [7] . In the brewing industry immobilized cells (yeast cells) are used to increase the productivity in fermentation and maturation [8, 9] . Immobilized yeast are also reported for wine and cider production [2, 10] , giving an overall costs reduction [10] . The increase in productivity is a consequence of the continuous operations practicable with encapsulated cells [11] , increased cell density, facilitated cell recovery and re-use, enhanced yeast stability, increased yeast tolerance to ethanol and acetic acid, increased fermentation time, protection from harsh environments, reduced contamination [2, 11] . Encapsulated yeast in alginate and carregeean beads are also reported as biocatalysts in organic solvents for complex reduction reactions [12] . There are reports [13] of the use of immobilized yeast in a polyacrylamide hydrogel for the production of L-phenylacetyl carbinol; an intermediate in the synthesis of L-ephedrine (used as an antiasthmatic and decongestant). Yeast cells were also encapsulated in colloidosomes, preserving their metabolic activity [14] . S. Graff et al. work [15] reported that the yeast species S. Boulardii has proven probiotic activity, and is being used for the treatment of enteritis, colitis and as antidiarrhoea agent. S. Boulardii is sensitive to the acidic environment in the stomach and by encapsulating in alginate beads it is a possible to protect the cells and increase the intestinal delivery.
To achieve a targeted drug release in the intestinal area, it is also possible to coat the microparti-cles using a proprietary coating material, resistant to the acidic stomach environment but which is soluble in basic-neutral conditions: Eudragit S100 [16] . The pH dependent polymer Eudragit S100 is used in drug delivery for the production of colonic delivery systems [17] ; it is an anionic copolymer based on methacrylic acid and methyl methacrylate which dissolves above pH 7. Eudragit coated microparticles were produced for the colonic release of therapeutics [16, 18] or proteins [19] , but it has not yet been applied for the coating of encapsulated cells. A variety of materials have been tested for the encapsulation of living cells; alginate [4, 6, 8, 12, 15, [20] [21] [22] [23] is the most common and versatile, chitosan [9, 23] , gelatin [22, 24] , cellulose [23, 25] , agarose [23, 26] , dextran [1] , carrageenan [9, 12, 27] , poly(lactide-co-glycolide) (PLGA) [1, 23] , Poly (Ethylene Glycol) [23, 28] all have been used individually, and in blends [1, 27] . Chitosan is a proven biocompatible natural polymer produced from natural sources (crustacean shells, fungi, and insects), which has been widely used for cell encapsulation and other pharmaceutical purposes [23, 29] . Its popularity is due to the possibility to prepare the hydrogel under relatively mild gelation conditions [30] using negatively charged ions and molecules, such as tripolyphosphate [31] or hexametaphosphate [32] . Chitosan is particularly advantageous as a material for the encapsulation of delicate compounds such as cells. In some cases the presence of positive charges of chitosan can interfere with the function of some cells and ionically crosslinked chitosan is not as mechanically stable as polymerized materials. To improve the mechanical and biological proprieties, chitosan is often used in association with other polymers, such as gelatin [23, 33] . Gelatin presents many advantages as a material for cell encapsulation: it is non-toxic and biodegradable, and it is extensively used in the pharmaceutical industry as an excipient [33] . A further advantage of gelatin is its ability to form hydrogels by thermal gelation, by decreasing the temperature below 20°C, and that it will melt again at body temperature (~37°C) [34] . In other work, glutaraldehyde crosslinked chitosan/gelatin microparticles were produced and tested, providing reported good biocompatibility and cytotoxicity of the two materials [33] .
Associated with the right material, the choice of the right encapsulation technique is fundamental for the success of an encapsulation process. Many techniques for cell encapsulation have been reported, including interfacial polymerization [12] and solvent evaporation [7] , sol-gel process [35] , photolithography [28] , ionic crosslinking [27] . In some cases, these techniques involve the prior formation of polymeric droplets in an oil-organic phase. The use of: organic solvents; harsh environments; high shear stress and high temperature, are all disadvantages for the encap-sulation of delicate organic material such as cells. Thus, the process of particle formation has to be carefully selected. Droplet production can essentially be classified in to two types: single or series drop formation techniques (extrusion-laminar jet break-up [15] ; microfluidic devices [21] ), and bulk or parallel techniques (stirring [7, 36] ; Membrane Emulsification (ME) [20] )). To-date, Song et al. [20] is the only work reported for the encapsulation of cells using an SPG membrane.
In that work there were no details of cell density used. ME is not an obvious choice for cell encapsulation: the microfilters used would be expected to filter out the suspended cells, rather than allow the passage of the cells from one side of the membrane to the other. ME being a method to produce emulsions that consists of injecting the dispersed phase for the emulsion through the pores of a membrane into another phase [37] . The detachment of the drops is produced by applying a shear over the membrane surface [38] . The method applies in a variety of emulsion types:
oil-in-water (O/W), water-in-oil (W/O) and double or multiple emulsions [39] . The method overcomes some of the disadvantages typical for other techniques of emulsions production (high pressure homogenization, rotor-stator systems) including poor droplet size uniformity, problematic scale-up, application of high mechanical forces (high shear) [40] . With ME it is possible to produce reasonably uniform emulsions with the desired droplet size by modifying the operating parameters of the process. It uses low shear conditions and requires low energy input [38, 41] . ME is easier to scale up and has a higher productivity compared to the other "drop-by-drop" methods of emulsion production (microchannel and microfluidic devices) [42] . All these characteristics make ME particularly advantageous for the encapsulation of shear sensitive, temperature sensitive and delicate compounds such as drugs, proteins and cells, provided that it can be shown that the membrane used for the emulsification does not filter out the cells to be encapsulated. The tortuous pore channel microfilters (porous glass and ceramic) are most likely to deposit particulate matter (i.e. cells) within the membrane matrix over a period of time.
An alternative ME system, used in this work, employs a flat disk membrane with straight rectilinear [29] pores in a regular array [37] . The lack of a tortuous pore channel minimizes membrane fouling, or cell filtration, during the process of encapsulation. In this work the Dispersion Cell Membrane Emulsification device [29, 37, 40, 42] is used for the production of W/O emulsions containing yeast cells using micro-sieve type metal membranes made hydrophobic by a process of surface coating. The performance of hydrophobic membranes coated with different methods (PTFE and FAS fluorinated compounds) is shown. Compared to SPG and ceramic membranes, the micro-sieve metal membranes can be cleaned more easily and tolerate higher fluxes [43] . The micro-sieve metal membranes are appropriate for cell encapsulation, as conditions that may cause membrane blockage, or cell filtration, can be avoided. Microparticles made of blended chitosan with gelatin, or pure gelatin, were produced for the encapsulation of yeast and the simulated release of yeast into the intestine-colon was investigated. To prevent the premature release of the yeast in the stomach, an acid resistant coating agent (Eudragit S100) was used.
Experimental

Materials
The oil phase (O) of the W/O emulsion was 2 wt.% Sorbitan monooleate, SPAN 80 (Sigma Aldrich, UK) in low odor kerosene (Sigma Aldrich, UK). The emulsion water phase (W) was composed of blended chitosan (CS) (MW 50.000-190.000 g/mol Sigma Aldrich, UK) and gelatin (G) from porcine skin, gel strength 300, Type A (Sigma Aldrich, UK), or gelatin in deionized water without CS. Chitosan and gelatin solutions were prepared separately and mixed together afterwards; chitosan is soluble in acetic acid solution (Fisher Scientific, UK) with a pH below 6 [29] .
CS was dissolved in warm (50-60ºC) 2 wt.% glacial acetic acid in water. Gelatin solution was prepared by dissolving gelatin in warm water (50-60ºC) . For the preparation of the blend, the two polymeric solutions were mixed together in an appropriate ratio and stirred for at least 2 hours, at 40ºC to avoid the gelatin coagulation. Where appropriate, the dispersed phase contained Baker's yeast cells (Saccharomyces cerevisiae) purchased from a supermarket (Sainsbury's Fast Action Dried Bread Yeast). The median size of the yeast cells was 4 µm, determined using the Javabased image processing package ImageJ on microphotographs taken using an optical/fluorescent microscope (GXML3201, GX microscope) with an attached Retiga 6000 colour camera. To make a yeast suspension 3.5 g of the dried yeast powder was added to 200 mL of ultrapure water and stirred for at least 10 minutes, after complete dissolution the suspension was centrifuged at 1200 RPM for 3 minutes. The supernatant was discarded and the washing procedure was repeated 3 times. The final volume of water removed was 175 mL. Considering the yeast cell as having a spherical shape with an average diameter of 4 µm and a dry mass density of 1.33 g mL -1 , the calculated maximum concentration of yeast in the suspension was 3.14 x 10 9 cells mL -1 . The initial cell suspension was subsequently diluted for use by factors of 10 and 100, giving cell concentrations of 3.14 x 10 7 and 3.14 x 10 8 cells mL -1 . Cell counting was also performed as a check, and a number higher than 3.18 x 10 9 cells mL -1 for the stock suspension was measured, thus the lower cell density calculated from the initial weighed yeast was considered more reliable for cell density characterization. The yeast cell density used for the reported tests is in accordance, or higher than, the generally accepted required dose of probiotics having health benefits (10 6 -10 7 cells/ mL [44] ). For the G:CS blend crosslinking was performed using a solution of sodium hexametaphosphate, SHMP (Fisher Scientific, UK) in water.
Polymer Eudragit S100 (Evonik Industries, Germany) was used for coating the microparticles:
Eudragit S100 was dissolved in a solution of ethanol: acetone ( Table 1 .
Dispersion Cell Membrane Emulsification
The W/O emulsion was prepared using a flat disk metal membrane in a Dispersions Cell sup- 
Experimental procedure
W/O emulsion production
In the Dispersion Cell the disk membrane is placed in the base, underneath a glass cylinder on which an impeller is mounted, see Fig.1 . The continuous phase of the emulsion is poured into the glass cylinder submerging the impeller and the membrane surface. The dispersed phase was injected into the system using a syringe pump (World Precision Instrument Inc., AL-1000, UK)
forcing it to permeate through the membrane pores. The dispersed phase injection rate was between 1 to 5 mL min -1 corresponding to a transmembrane flux between 70 and 350 L h -1 m -2 . In order to increase the membrane hydrophobicity, the membrane was soaked at least 30 minutes in kerosene with no surfactant present. The glass cylinder was filled with just less than 100 cm 3 of continuous phase, and the amount of dispersed phase injected was 10 cm 3 (10 vol.% concentration emulsion). The whole Dispersion Cell was placed in a water bath and the emulsification process run at 40ºC. When the emulsification was completed the pump and the stirrer were switched off and the produced emulsion was poured from the glass cylinder into a beaker (with stirring) and analyzed. The Dispersion Cell was subsequently disassembled and the membrane washed. The membrane washing procedure consisted of removing the kerosene by washing the membrane with running water and using soap. Afterwards, the membrane was soaked in soapy water and sonicated for a maximum of 30 seconds using an ultrasonic bath. The membrane was then rinsed with water and dried with compressed air. The sizes of the aqueous phase drops in kerosene and size distribution were determined using the software ImageJ on microphotographs of the emulsions, and at least 300 drops per sample were measured. The droplet size was reported as D av , mean average droplet diameter using the following formula:
Where d i is the i th diameter of the droplet, n i is the number of drops in the size range and N is the total number of the droplets counted. The uniformity of the emulsion is reported as a value of Coefficient of Variation % (CV%) calculated as follows:
Microparticle solidification
To obtain solid microparticles, the liquid drops in emulsion were solidified using either a thermal gelation process, or ionic crosslinking using SHMP. For the dispersed phase composed by the blend of G:CS in a ratio of 5:2 (G:CS (5:2)) the emulsion was initially cooled with ice for 30 minutes to set the gelatin, subsequently 10 mL of a 10 wt.% SHMP solution was gently dripped into the emulsion to crosslink the chitosan. The reaction occurred under continuous stirring for 3 hours. When pure gelatin (5 wt.% gelatin in water) was used as dispersed phase, the drop solidification was obtained by thermal gelation: cooling the emulsion using an ice bath, under continuous stirring for 4 hours. In both cases the obtained solid particles were washed using 2 wt.% Tween 20 in water to remove any remaining kerosene phase.
Microparticle coating
Coating was performed on gelatin particles using the oil in oil (O 1 /O 2 ) solvent evaporation method previously described by L. Zhang et al [16] . The polymeric coating solution (O 1 ) was prepared using 2 wt.% Eudragit S100 dissolved in a solution of ethanol:acetone at a volume ratio of 4:1. To prevent microparticle aggregation during the subsequent coating process, 20 mg of zinc stearate was added to the organic phase which acted as an anti-sticking agent. The zinc stearate was not completely soluble in the coating solution therefore, to minimize the zinc stearate particle diameter the coating mixture was homogenized using an homogenizer (IKA® T 10 ULTRA-TURRAX®, Germany) at maximum speed (30,000 RPM) for 3 min. 3 mL of gelatin microparticles suspension was added to 10 mL to the coating solution (O 1 ) and stirred for 2 minutes providing a uniform dispersion of the particles. Coating solution (O 1 ) containing the microparticles was gently poured in to 50 mL of 2 wt.% SPAN 80 in Paraffin (O 2 ). The O 1 /O 2 emulsion was stirred using the Dispersion Cell impeller at 5V (corresponding to 800 RPM) for 4 hours. The process of solvent evaporation was checked every hour; samples of the O 1 /O 2 emulsion were withdrawn and examined under the optical microscope. Reduction of the O 1 droplet size was observed until complete solvent evaporation and Eudragit polymer deposition on the gelatin microparticles oc-curred. The coated microparticles were washed using hexane and dried at room temperature overnight.
Yeast loaded microparticles -dissolution study
Simulation of the gastro-intestinal transit conditions was obtained varying the pH of the dissolution medium over time: the acidic stomach fluid was reproduced using a pH 1.2 for 2 hours, afterwards a pH 7 (or pH 8) medium was used to mimic the intestinal-colon area for a maximum period of time of 3 hours (or up to complete particle dissolution) [18] . The dissolution medium was prepared from a phosphate buffer saline (PBS, Sigma Aldrich, UK) solution (pH 7), adjusting the pH with hydrochloric acid (Sigma Aldrich, UK), or sodium hydroxide (Sigma Aldrich, UK). An initial amount of 15 mg of dried particles was added to 1 mL of dissolution medium at pH 1.2 and shaken in an incubator at 37ºC for 2 hours. After 2 hours in an acidic environment, the microparticles were observed under the microscope and subsequently collected from the acidic buffer and resuspended in 1 mL of pH 7 buffer for maximum 3 hours with shaking. Again the microparticles were recovered and observed, then re-suspended in pH 8 buffer. Microphotographs of the microparticles were taken at regular time intervals, until dissolution of the particles and complete cell release.
Released yeast viability determination
The viability of the released cells from the microparticles was tested using two methods: yeast 
Results and discussion
Influence of emulsification process parameters and cells presence on droplet size and uniformity
Variation of droplet average diameter and uniformity with dispersed phase flux and shear stress was investigated using a dispersed phase containing either 5 wt.% gelatin mixed with 2 wt.% Fig. 2(a) , it is shown that D av decreases with increasing shear stress. This trend is in accordance with data reported previously [29, 37, 42] . Modifying the shear stress applied it was possible to produce droplets sized between 60 µm to 340 µm using the 30 µm membrane. The corresponding CV% (Fig. 2(b) ) was in a range between 17 to 30%. 
where V o is the volume of the drop predicted by a force balance, e.g. equation (3), and tJ is the extra volume of the drop caused by operating at a high injection rate and the finite time required for droplet formation [46] . However, in order to apply equation (4) the drop formation time has to be assessed and this will depend on the fraction of pores that are actively generating drops, which is rarely a known value. Thus, for the purpose of illustrating the key parameters influencing the drop formation in the system studied here the simple force balance model, as represented by equation (3), is presented. Fig. 4 (a) shows the mean droplet size as a function of the yeast concentration: it is possible to see that the amount of cells did not affect the size of the emulsion produced. Using these operating parameters, drops sized ~66 µm were obtained, a good uniformity was achieved with a CV between 19 and 23% as reported in Fig. 4 (b) . A cell concentration of 3.14 x 10 8 cells work, and, therefore, the encapsulation efficiency of the yeast cells will be 100%.
Effect of membrane coating on droplet size and uniformity
The importance of membrane wettability was demonstrated by Nakashima et al. [47] , who showed that membrane wetting by the dispersed phase should be avoided for successful production of monodispersed emulsions. Therefore, in the production of W/O emulsions, the membrane should be thoroughly wetted by the continuous oil phase, in order to minimize the spreading of the dispersed phase on the membrane. Hydrophobic membranes can be produced by a process of coating of a surface with different materials [48, 49] . The PTFE coated nickel membrane used gave reasonably monodispersed emulsions Fig. 7 (a) . Under the best operating conditions a CV of the 17% was achieved. However, a PTFE coated membrane requires a delicate washing procedure to avoid membrane coating damage: warm soapy water and an ultrasonic bath for a maximum of 30 s was used for the washing. The PTFE coated membrane had a thermally bonded polymer coating on the metal surface, which made recoating the membrane (to maintain its hydrophobicity with multiple use) troublesome. To overcome this disadvantage, a FAS coated membrane was also tested for the production of the W/O emulsion.
The results obtained using the two membranes are compared in 82 µm while the calculated CV% was 22 %. The drops produced using the FAS coated membranes were noticeably larger in size than the ones produced using the PTFE coated membrane, suggesting that the PTFE coated membrane has a greater degree of hydrophobicity than the FAS coated membrane, when new. However, the simplicity of FAS coating may make it more practical for membranes intended for multiple uses.
Process of drop solidification: thermal gelation and ionic crosslinking.
For the dispersed phase composed by G:CS (5:2) the solidification process consisted of two steps: initially the emulsion was placed in ice to decrease the temperature to approximatively 0ºC, this induced the hardening of gelatin. After 30 minutes in ice, 10 mL of 10 wt.% sodium hexametaphosphate solution was gently dripped in to the emulsion. The mixture was stirred for 4
hours to complete the solidification of the two polymers keeping the temperature at 0ºC. The addition of the phosphate salt induced a gelation of the chitosan present in the polymeric mixture; hexametaphosphate anions provide strong electrostatic interactions with the positively charged amino groups of chitosan, acting as a physical crosslinker [32] . The combination of thermal gelation and ionic crosslinking produced solid microparticles; no difference in size was observed between the liquid droplets and the solidified microparticles re-suspended in water.
Once dried at room temperature, the microparticles formed a free flowing powder. The yeast cells were immobilized into the solid polymeric material. Gelatin microparticles were also produced (with no CS present), several concentrations of gelatin in water were tested (1 to 5
wt.%). For the solidification of this formulation, thermal gelation in ice was exploited. It was seen that if gelatin concentration was below 5 wt.% the particles did not form, even after increasing the gelation time. The selected concentration for the production of the gelatin particles was, therefore, 5 wt.%. Unlike the G:CS (5:2) particles, the pure gelatin particles did not survive the drying process, the particles collapsed forming clusters of polymer and losing their spherical shape. For that reason the gelatin particles were washed and directly re-suspended in water. The gelatin microparticles re-suspended in water showed an increase of average diameter when compared to the diameter of the drops in the kerosene phase. For gelatin drops sized 76±2 µm on average, gelatin microparticles (re-suspended in water) had a diameter of 100± 2 µm. This effect could be due to water absorption and swelling of the gelatin particles once re-suspended in water after the process of washing.
Influence of the Eudragit coating on the physical proprieties of the gelatin microparticles
To protect the particles form an acidic environment coating of the particles formed by Eudragit S100 was performed. The coating was not performed on the G:CS particles as they did not dissolve within the gastro-intestine timeframe; i.e. they did not need to be protected. The coating reaction occurred in 4 hours, the reaction was monitored by observation of the particles in the O 1 /O 2 emulsion during the formation of the Eudragit shell. Fig. 8 (a) shows an uncoated gelatin particles suspended in water, an image of the early stage of the reaction (t= 0 minutes) is shown in Fig. 8 (b) : a liquid shell surrounding the gelatin drop surface composed by the organic phase containing the coating material dissolved is visible. With the evaporation of the solvent, the Eudragit polymer gradually formed a solid layer; visible in Fig. 8 (c) . The reaction was stopped and considered complete once the O 1 drops were almost invisible leaving the solid Eudragit polymer. The particles were washed and dried at room temperature, giving a white powder. A small sample of coated particles was re-suspended in water and observed under a microscope. Fig.8 (d) shows one of the coated particles re-suspended in water. Compared to the un-coated microparticles, the coated ones are smaller in size: the mean size of un-coated particles (in water) was 100±2 µm, and water wet coated microparticles were 70±2 µm in diameter. The water is extracted from the particles by the O 1 phase during the process of coating producing shrinkage.
When re-suspended in water the coating layer prevents water absorption, thus swelling is reduced.
Un-coated and coated particles: dissolution pH and temperature dependence release of the yeast cells.
In-vitro release studies were performed on the particles to test the yeast release with time at different pH of the medium. All the experiments were carried out at 37ºC. Three formulations were used for this test and compared. Fig. 9 shows images of the particles at different pH and time intervals. The yeast encapsulated particles made of G:CS (5:2) did not show any cell release; this formulation was extremely resistant to the acidic environment (pH 1.2) and to neutral (pH 7) conditions even after 5 days. The crosslinked matrix did not dissolve as shown in Fig. 9 (a) . The trapped yeast cells were immobilized within the polymeric matrix and the formulation failed to release the cells. Behavior of the G:CS formulation at the tested pH can be explained by the formation of a strong ionically crosslinked polymeric matrix. A complex coacervation occurs between proteins and the polyanion [50] preventing the dissolution of the two polymers in the release medium. No further analyses were conducted on this formulation. Fig. 9 (b) shows the gelatin microparticles that were initially placed at pH 1.2, to mimic the stomach conditions. Unlike the previous formulation, the pure gelatin particles released very rapidly; they did not resist the acidic environment and released their contents after 5 minutes.
The test was also conducted at neutral pH (pH 7), in this case the gelatin particles dissolved slower, after 15 minutes the yeast particles were swollen and almost invisible, but the encapsulated yeast was still retained inside the polymer. After a time of 30 minutes, the gelatin particles were completely dissolved and the content released in the surrounding medium. The pure gelatin microparticles did not meet the requirements for a gastro-resistant formulation: they did not protect the yeast cells from the acidic environment of the stomach for a period of at least 2 hours [18] . Therefore, the Edudragit S100 coating was added to the gelatin particles to preserve the gelatin polymer during the residence at pH 1.2; allowing dissolution of the particles only in a neutral, or basic, environment (pH between 7 and 8) typical of the intestinal-colonic area [17] .
Eudragit coated microparticles were tested and the results are shown in Fig. 9 (c) . In the images, background debris of the coating material is present. At pH 1.2, after two hours, the microparticles still encapsulate the yeast without alteration of their shape, or swelling. The coated microparticles were removed from the acidic medium and transferred to a neutral environment at pH 7; no change was visible after 30 minutes, but a significant modification is noticeable after 2 hours: the coating gradually dissolve, for some particles a visible breaking of the Eudragit shell exposing the gelatin internal part is noticeable. At this stage, however, the cells were not released from the internal gelatin matrix. After 3 hours the microparticles were completely dissolved and the structure was no longer visible, the yeast cells were released and they are visible as small spots on the background of the image. In a basic environment the release was faster: it is possible to see that after 15 minutes at pH 8 the external coating was almost dissolved, but the particle shape is still visible. In 30 minutes the microparticles released completely the content, some residual part of the particles is still visible. Although the yeast cells were already released, the complete dissolution of the residual polymer was observed after 1 hour. The Eudragit S100 methacrylic polymer is insoluble in acids, protecting the microparticles from dissolution in the stomach environment. However, the formed Eudragit S100 layer on the gelatin microparticles dissolves at pH above 7, leaving the gelatin material exposed, and simple melting of the gelatin at 37°C produced the release of yeast cells in this medium.
Yeast cell viability test
Glucose consumption analysis
Yeast cells released from Eudragit S100 coated gelatin microparticles (Fig. 9 c) were collected and transferred into a 6mM glucose solution. The glucose concentration was measured at regular time intervals to check for yeast cell viability. Fig. 10 shows the reduction in glucose
concentration measured with time, in terms of glucose consumed. The test was repeated for three samples. In the graph, the glucose consumed is reported as the percentage of the initial glucose amount consumed by the free yeast; calculated using the formula:
Where is the initial glucose concentration (6 mM), is the amount of glucose measured in the sample. The glucose was metabolized by the released cells with time reaching 90% consumption in 24 hours. This data shows that the encapsulation process did not damage the cells and that they were successfully protected from an acidic environment (pH 1.2), equivalent to the conditions of the stomach, and after release when the conditions are no longer acidic the cells are still viable.
Fluorescent analysis
Two Fluorescent probes for cell dyeing were used to distinguish living cells from dead cells.
Using an epifluorescence microscope the yeast cells encapsulated in the Eudragit coated particles (Fig. 9 c) and the yeast released from the particles (Fig. 9 c) were observed. In Fig. 11 (a These conditions mimic what would be expected to occur during the passage of the encapsulated particles through the human gastric system. Thus successfully delivering living cells to the colon.
Conclusions
Dispersion Cell ME was used for the production of W/O emulsions with hydrophobic was performed using a live/dead cell staining with two fluorescent probes which showed that living yeast cells predominated. Yeast cells were chosen as a proof of concept showing that ME is a promising method for cell encapsulation; the process can be applied to a variety of micro-organisms according to the cell type and specific requirements, notably cell density and flow rate, provided that the membrane structure is non-tortuous as this does not filter the yeast cells from the injected phase within the matrix of the membrane.  PTFE coated metal membrane, had high hydrophobicity and produced small drops.
 Gelatin and gelatin/chitosan microparticles were used to encapsulate yeast cells  Eudragit S100 coated particles provided targeted release in neutral/ basic conditions  Glucose consumption with time and live/dead staining confirmed cell viability
